תבנית:תרופה/סירקדין - Circadin

× ×ª×× × ×ª×¨××¤×

×××¨×©×

×§×××¦× ×¤×¨××§××××××ª (ATC4)	N05CH Melatonin receptor agonists
××¨××× ×¤×¢×× (ATC5)	Â Melatonin 2MG âN05CH01 Melatonin 2MG âN05CH01 Melatonin receptor agonists N05CH âN05CH01 Rua consiglieri pedroso, n0 121-123 QUELUZ DE BAIXO, 2745-557 BARCARENA, PORTUGAL manufacturing , release , quality control , packaging âN05CH01 Melatonin 2MG âN05CH01
×¦××¨×ª ××ª×	×¤××× - PER OS
×¦××¨×ª ××× ××	TABLETS PROLONGED RELEASE
××ª××××	Short-term treatment for primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
××ª×××ª ××× ××	Posology and method of administration
××ª×××××ª × ××	Contraindications
×ª××¤×¢××ª ×××××	Undesirable effects
×ª×××××ª ××× ×ª×¨××¤×ª×××ª	Interaction with other medicinal products and other forms of interaction
×©××××© ××××¨××× ××× ×§×	Pregnancy and Lactation
×¤×¨××§×××× ×××§×	Pharmacodynamic Properties
×¤×¨××§××§×× ×××§×	Pharmacokinetic Properties
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	×¢××× ××¨××¤× ××××¨× ××¢×××

×¢××× ××¦×¨××	*×¢××× ××¦×¨×× ×¢××× ××¦×¨×× ×¢××× ××¦×¨××

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×¡××¨×§××× Â® ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	-
××××¢ ××¨×©×ª	-
×©× ××¦×¨×	NEURIM PHARMACEUTICALS LIMITED
×©× ××¢× ××¨××©××	NEURIM PHARMACEUTICALS LIMITED
×¨××©×××	×ª××¨×× ×××©×: 09/2015. ×¨××©××× ××ª××¨××: 09/2015
×ª××¨×× ×¢×××× ×××¨××	14/05/19

××£ ×× × ××¦×¨ ×¢× ××× ××× ××××××¨ ×ª×× ××ª ×¢× ×¤×¨×× ××ª×¨××¤×.

{{×ª×¨××¤×/×¡××¨×§××× - Circadin}}

×:

{{×ª×¨××¤×/×¡××¨×§××× - Circadin
| ×©× ××¤×¨×××¨=×¢×¨× ×××© (×××¨×¡ ××ª ××¢×¨× ×©×××× ×××××¨)
}}

השינוי האחרון נעשה בֹ־7 באפריל 2021 ב־12:21

ויקיתרופות